查找地点
有关时间、上门服务和预约查找地点
有关时间、上门服务和预约Pertinent medical findings should accompany the test request form. Please direct questions to genetic customer service at 800-345-4363.
There may be an additional charge for formalin positive tissuesamples requiring embedding and pathology.
14 - 21 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
|
14 - 21 days |
Formalin fixed paraffin embedded (FFPE) tissue
Formalin fixed paraffin embedded (FFPE) tissue Formalin fixed paraffin embedded (FFPE) tissue |
Formalin fixed paraffin embedded (FFPE) tissue Formalin fixed paraffin embedded (FFPE) tissue |
One paraffin block or ten 10-micron thick section slides
Extracted DNA from received specimen must yield at least 10 ul at a concentration of 8 ng/ul.
Paraffin block transport pouch
FFPE specimen should be fixed in 10% neutral-buffered formalin or formaldehyde.
FFPE specimen should be fixed in 10% neutral-buffered formalin or formaldehyde. FFPE specimen should be fixed in 10% neutral-buffered formalin or formaldehyde. |
FFPE specimen should be fixed in 10% neutral-buffered formalin or formaldehyde. FFPE specimen should be fixed in 10% neutral-buffered formalin or formaldehyde. |
Room temperature
Improperly embedded preparation; decalcified bone or bone core; no fetal visualized on pathology report; only a small area is identified on fixed sample as fetal, and is less than 50% of sample
For products of conception samples, this test will detect chromosomal imbalance that could be associated with developmental delay/congenital anomalies. It provides detection of possible uniparental disomy of any chromosome, the percent and location of homozygosity, including the degree of identity by descent. For oncology samples, this test will detect chromosomal imbalances that may be present in neoplastic disorders and clonal evolution. It provides detection of copy-neutral loss of heterozygosity of any chromosome, and the percent and location of homozygosity, that may be associated with cancer gene mutation.
This SNP assay does not detect balanced rearrangements, low-level mosaicism (<10%), marker chromosomes that only contain heterochromatin or tetraploidy. Genotypes in some formalin-fixed tissues are unable to be determined, allowing only genomic dosage to be determined.
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
This SNP assay does not detect balanced rearrangements, low-level mosaicism (<10%), marker chromosomes that only contain heterochromatin or tetraploidy. Genotypes in some formalin-fixed tissues are unable to be determined, allowing only genomic dosage to be determined. This test was developed and its performance characteristics determined by Lab |
This SNP assay does not detect balanced rearrangements, low-level mosaicism (<10%), marker chromosomes that only contain heterochromatin or tetraploidy. Genotypes in some formalin-fixed tissues are unable to be determined, allowing only genomic dosage to be determined. This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration. |
SNP Microarray analysis is performed using the Oncoscan® FFPE platform, which uses more than 220,000 SNP probes with a median spacing of 5.0kb, within the majority of genes.
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
512029 | Reveal(R) Data Transfer FFPE | 511998 | Specimen Type | 48002-0 | ||
512029 | Reveal(R) Data Transfer FFPE | 511999 | # of Genotyping Targets | N/A | ||
512029 | Reveal(R) Data Transfer FFPE | 512000 | Array Type | 62377-7 | ||
512029 | Reveal(R) Data Transfer FFPE | 512001 | Diagnosis | 62357-9 | ||
512029 | Reveal(R) Data Transfer FFPE | 512002 | Interpretation | 62373-6 | ||
512029 | Reveal(R) Data Transfer FFPE | 512003 | Director Review | 48672-0 | ||
512029 | Reveal(R) Data Transfer FFPE | 512123 | 51967-8 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf